Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
  • Antioxidant Function of Steen Solution, Mohamed S. A. Mohamed
    Oxidative Medicine and Cellular Longevity
    Letter to the Editor (2 pages), Article ID 578353, Volume 2014 (2014)
    Published 23 November 2014
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 242180, 10 pages
http://dx.doi.org/10.1155/2014/242180
Research Article

New Insights into the Steen Solution Properties: Breakthrough in Antioxidant Effects via NOX2 Downregulation

1Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, 00161 Rome (RM), Italy
2Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina (LT), Italy
3Department of Thoracic Surgery, Sapienza University of Rome, 00161 Rome (RM), Italy
4Fondazione Eleonora Lorillard Spencer Cenci, 00185 Rome (RM), Italy
5Department of Heart and Great Vessels, Sapienza University of Rome, 00161 Rome (RM), Italy
6Department of AngioCardioNeurology, IRCCS NeuroMed, 86077 Pozzilli (IS), Italy

Received 24 February 2014; Accepted 13 March 2014; Published 16 April 2014

Academic Editor: Daniela Giustarini

Copyright © 2014 Roberto Carnevale et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Maurer, A. E. Frost, M. Estenne, T. Higenbottam, and A. R. Glanville, “International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society,” The Journal of Heart and Lung Transplantation, vol. 17, no. 7, pp. 703–709, 1998. View at Google Scholar · View at Scopus
  2. J. D. Christie, L. B. Edwards, A. Y. Kucheryavaya et al., “The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report-2011,” Journal of Heart and Lung Transplantation, vol. 30, no. 10, pp. 1104–1122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Kawut, A. Reyentovich, J. S. Wilt et al., “Outcomes of extended donor lung recipients after lung transplantation,” Transplantation, vol. 79, no. 3, pp. 310–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Ingemansson, A. Eyjolfsson, L. Mared et al., “Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo,” Annals of Thoracic Surgery, vol. 87, no. 1, pp. 255–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. de Meester, J. M. A. Smits, G. G. Persijn, and A. Haverich, “Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience,” Journal of Heart and Lung Transplantation, vol. 20, no. 5, pp. 518–524, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Abecassis, N. D. Bridges, C. J. Clancy et al., “Solid-organ transplantation in older adults: current status and future research,” The American Journal of Transplantation, vol. 12, no. 10, pp. 2608–2622, 2012. View at Google Scholar
  7. H. Date, T. Shiraishi, S. Sugimoto et al., “Outcome of living-donor lobar lung transplantation using a single donor,” The Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 3, pp. 710–715, 2012. View at Google Scholar
  8. P. Frati, “Organ transplantation from living donors, between bioethics and the law,” Transplantation Proceedings, vol. 37, no. 6, pp. 2433–2435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Steen, T. Sjöberg, L. Pierre, Q. Liao, L. Eriksson, and L. Algotsson, “Transplantation of lungs from a non-heart-beating donor,” The Lancet, vol. 357, no. 9259, pp. 825–829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Cypel, J. C. Yeung, L. Mingyao et al., “Normothermic ex vivo lung perfusion in clinical lung transplantation,” The New England Journal of Medicine, vol. 364, no. 15, pp. 1431–1440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Wallinder, S. E. Ricksten, M. Silverborn, and C. Hansson, “Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study,” Journal of Cardiothoracic Surgery, vol. 45, no. 1, pp. 40–45, 2014. View at Google Scholar
  12. P. Pignatelli, R. Carnevale, R. Cangemi et al., “Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 360–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Fortuño, J. Bidegain, P. A. Robador et al., “Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension,” Hypertension, vol. 54, no. 4, pp. 744–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. El-Benna, P. M. C. Dang, M. A. Gougerot-Pocidalo, J. C. Marie, and F. Braut-Boucher, “p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases,” Experimental and Molecular Medicine, vol. 41, no. 4, pp. 217–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sugamura and J. F. Keaney Jr., “Reactive oxygen species in cardiovascular disease,” Free Radical Biology and Medicine, vol. 51, no. 5, pp. 978–992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Violi and P. Pignatelli, “Platelet oxidative stress and thrombosis,” Thrombosis Research, vol. 129, no. 3, pp. 378–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Pignatelli, R. Carnevale, S. di Santo et al., “Inherited Human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 423–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Pignatelli, V. Sanguigni, L. Lenti et al., “gp91phox-dependent expression of platelet CD40 ligand,” Circulation, vol. 110, no. 10, pp. 1326–1329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Seno, N. Inoue, D. Gao et al., “Involvement of NADH/NADPH oxidase in human platelet ROS production,” Thrombosis Research, vol. 103, no. 5, pp. 399–409, 2001. View at Publisher · View at Google Scholar · View at Scopus